Related Articles:

Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents

[Sohda; Mizuno; Momose; Ikeda; Fujita; Meguro Journal of Medicinal Chemistry, 1992 , vol. 35, # 14 p. 2617 - 2626]

Design and synthesis of N-[(4-methoxyphenoxy) carbonyl]-N-[[4-[2-(5-methyl-2-phenyl-4-oxazolyl) ethoxy] phenyl] methyl] glycine [muraglitazar/BMS-298585], a novel …

[Devasthale, Pratik V.; Chen, Sean; Jeon, Yoon; Qu, Fucheng; Shao, Chunning; Wang, Wei; Zhang, Hao; Cap, Michael; Farrelly, Dennis; Golla, Rajasree; Grover, Gary; Harrity, Thomas; Ma, Zhengping; Moore, Lisa; Ren, Jimmy; Seethala, Ramakrishna; Cheng, Lin; Sleph, Paul; Sun, Wei; Tieman, Aaron; Wetterau, John R.; Doweyko, Arthur; Chandrasena, Gamini; Chang, Shu Y.; Humphreys, W. Griffith; Sasseville, Vito G.; Biller, Scott A.; Ryono, Denis E.; Selan, Fred; Hariharan, Narayanan; Cheng, Peter T. W. Journal of Medicinal Chemistry, 2005 , vol. 48, # 6 p. 2248 - 2250]

Design and synthesis of N-[(4-methoxyphenoxy) carbonyl]-N-[[4-[2-(5-methyl-2-phenyl-4-oxazolyl) ethoxy] phenyl] methyl] glycine [muraglitazar/BMS-298585], a novel …

[Journal of Medicinal Chemistry, , vol. 48, # 6 p. 2248 - 2250]

Azole phenoxy hydroxyureas as selective and orally active inhibitors of 5-lipoxygenase

[Journal of Medicinal Chemistry, , vol. 39, # 1 p. 237 - 245]

Azole phenoxy hydroxyureas as selective and orally active inhibitors of 5-lipoxygenase

[Journal of Medicinal Chemistry, , vol. 39, # 1 p. 237 - 245]